Molecular mechanisms of the anti-inflammatory functions of interferons

Immunobiology

Volumn 212, Issue 9-10, 2008, Pages 895-901

  Kovarik, Pavel ^a   Sauer, Ines ^a   Schaljo, Barbara ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokine; Inflammation; Interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TWIST; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; BACTERIAL IMMUNITY; CACHEXIA; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOST RESISTANCE; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PARASITE IMMUNITY; PATHOGENESIS; POLYARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; VIRUS IMMUNITY;

EID: 37049037995     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.09.011     Document Type: Article

References (58)

1. Akwa Y., Hassett D.E., Eloranta M.L., Sandberg K., Masliah E., Powell H., Whitton J.L., Bloom F.E., and Campbell I.L. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161 (1998) 5016-5026
2. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W., Nicola N.A., Hertzog P.J., Metcalf D., and Hilton D.J. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98 (1999) 597-608
3. Baccala R., Kono D.H., and Theofilopoulos A.N. Interferons as pathogenic effectors in autoimmunity. Immunol. Rev. 204 (2005) 9-26
4. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity 14 (2001) 661-664
5. Blackshear P.J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30 (2002) 945-952
6. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15 (1997) 749-795
7. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12 (2000) 419-424
8. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 (1998) 1001-1005
9. Carrick D.M., Lai W.S., and Blackshear P.J. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res. Ther. 6 (2004) 248-264
10. Decker T., Muller M., and Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. 5 (2005) 675-687
11. Durbin J.E., Hackenmiller R., Simon M.C., and Levy D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84 (1996) 443-450
12. Fenner J.E., Starr R., Cornish A.L., Zhang J.G., Metcalf D., Schreiber R.D., Sheehan K., Hilton D.J., Alexander W.S., and Hertzog P.J. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 7 (2006) 33-39
13. Frucht D.M., Fukao T., Bogdan C., Schindler H., O'Shea J.J., and Koyasu S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 22 (2001) 556-560
14. Furlan R., Brambilla E., Ruffini F., Poliani P.L., Bergami A., Marconi P.C., Franciotta D.M., Penna G., Comi G., Adorini L., and Martino G. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 167 (2001) 1821-1829
15. Garcia-Sastre A., and Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312 (2006) 879-882
16. Gil M.P., Bohn E., O'Guin A.K., Ramana C.V., Levine B., Stark G.R., Virgin H.W., and Schreiber R.D. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98 (2001) 6680-6685
17. Guedez Y.B., Whittington K.B., Clayton J.L., Joosten L.A., van de Loo F.A., van den Berg W.B., and Rosloniec E.F. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44 (2001) 2413-2424
18. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D.F., Bell J.C., Hettmann T., Leiden J.M., and Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11 (2003) 619-633
19. Heremans H., Dijkmans R., Sobis H., Vandekerckhove F., and Billiau A. Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J. Immunol. 138 (1987) 4175-4179
20. Ho H.H., and Ivashkiv L.B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281 (2006) 14111-14118
21. Hu X., Ho H.H., Lou O., Hidaka C., and Ivashkiv L.B. Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction. J. Immunol. 175 (2005) 131-138
22. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147 (1957) 258-267
23. Karaghiosoff M., Neubauer H., Lassnig C., Kovarik P., Schindler H., Pircher H., McCoy B., Bogdan C., Decker T., Brem G., Pfeffer K., and Muller M. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13 (2000) 549-560
24. Karaghiosoff M., Steinborn R., Kovarik P., Kriegshauser G., Baccarini M., Donabauer B., Reichart U., Kolbe T., Bogdan C., Leanderson T., Levy D., Decker T., and Muller M. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat. Immunol. 4 (2003) 471-477
25. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., and Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115 (2005) 695-702
26. Kim S., Koga T., Isobe M., Kern B.E., Yokochi T., Chin Y.E., Karsenty G., Taniguchi T., and Takayanagi H. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 17 (2003) 1979-1991
27. Koltai M., and Meos E. Inhibition of the acute inflammatory response by interferon inducers. Nature 242 (1973) 525-526
28. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., and Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4 (2003) 69-77
29. Kovarik P., Mangold M., Ramsauer K., Heidari H., Steinborn R., Zotter A., Levy D.E., Muller M., and Decker T. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20 (2001) 91-100
30. Krakowski M., and Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26 (1996) 1641-1646
31. Lin W., Bailey S.L., Ho H., Harding H.P., Ron D., Miller S.D., and Popko B. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J. Clin. Invest. 117 (2007) 448-456
32. Manoury-Schwartz B., Chiocchia G., Bessis N., Abehsira-Amar O., Batteux F., Muller S., Huang S., Boissier M.C., and Fournier C. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 158 (1997) 5501-5506
33. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., and Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 (1996) 431-442
34. Pestka S., Krause C.D., and Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202 (2004) 8-32
35. Pilz A., Ramsauer K., Heidari H., Leitges M., Kovarik P., and Decker T. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons. EMBO Rep. 4 (2003) 368-373
36. Ramana C.V., Gil M.P., Han Y., Ransohoff R.M., Schreiber R.D., and Stark G.R. Stat1-independent regulation of gene expression in response to IFN- gamma. Proc. Natl. Acad. Sci. USA 98 (2001) 6674-6679
37. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., and Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 (2000) 539-548
38. Sauer I., Schaljo B., Vogl C., Gattermeier I., Kolbe T., Muller M., Blackshear P.J., and Kovarik P. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 107 (2006) 4790-4797
39. Schindler C., and Brutsaert S. Interferons as a paradigm for cytokine signal transduction. Cell. Mol. Life Sci. 55 (1999) 1509-1522
40. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2004) 163-189
41. Sharif M.N., Sosic D., Rothlin C.V., Kelly E., Lemke G., Olson E.N., and Ivashkiv L.B. Twist mediates suppression of inflammation by type I IFNs and Axl. J. Exp. Med. 203 (2006) 1891-1901
42. Shinoda K., Sugiyama E., Taki H., Harada S., Mino T., Maruyama M., and Kobayashi M. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes. Bone 33 (2003) 711-720
43. Shuai K., and Liu B. Regulation of JAK-STAT signalling in the immune system. Nature Rev. 3 (2003) 900-911
44. So E.Y., Park H.H., and Lee C.E. IFN-gamma and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression. J. Immunol. 165 (2000) 5472-5479
45. Sosic D., Richardson J.A., Yu K., Ornitz D.M., and Olson E.N. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112 (2003) 169-180
46. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., Yokochi T., Oda H., Nakamura K., Ida N., Wagner E.F., and Taniguchi T. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 (2002) 744-749
47. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., and Blackshear P.J. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 (1996) 445-454
48. Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R., and Issazadeh-Navikas S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170 (2003) 4776-4784
49. Treschow A.P., Teige I., Nandakumar K.S., Holmdahl R., and Issazadeh-Navikas S. Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice. Arthritis Rheum. 52 (2005) 3739-3748
50. Triantaphyllopoulos K.A., Williams R.O., Tailor H., and Chernajovsky Y. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy. Arthritis Rheum. 42 (1999) 90-99
51. Tzung S.P., Mahl T.C., Lance P., Andersen V., and Cohen S.A. Interferon-alpha prevents endotoxin-induced mortality in mice. Eur. J. Immunol. 22 (1992) 3097-3101
52. Varinou L., Ramsauer K., Karaghiosoff M., Kolbe T., Pfeffer K., Muller M., and Decker T. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 19 (2003) 793-802
53. Vermeire K., Heremans H., Vandeputte M., Huang S., Billiau A., and Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J. Immunol. 158 (1997) 5507-5513
54. Wang J., Lin W., Popko B., and Campbell I.L. Inducible production of interferon-gamma in the developing brain causes cerebellar dysplasia with activation of the Sonic hedgehog pathway. Mol. Cell. Neurosci. 27 (2004) 489-496
55. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
56. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., and Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 (1996) 3223-3227
57. Young H.A. Unraveling the pros and cons of interferon-gamma gene regulation. Immunity 24 (2006) 506-507
58. Yu M., Nishiyama A., Trapp B.D., and Tuohy V.K. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64 (1996) 91-100